CA2548173A1 - Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof - Google Patents

Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof Download PDF

Info

Publication number
CA2548173A1
CA2548173A1 CA002548173A CA2548173A CA2548173A1 CA 2548173 A1 CA2548173 A1 CA 2548173A1 CA 002548173 A CA002548173 A CA 002548173A CA 2548173 A CA2548173 A CA 2548173A CA 2548173 A1 CA2548173 A1 CA 2548173A1
Authority
CA
Canada
Prior art keywords
cancer
carcinoma
compound
leukemia
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002548173A
Other languages
English (en)
French (fr)
Inventor
Eliezer Flescher
Yoel Kashman
Dorit Reischer
Shiri Shimony
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2548173A1 publication Critical patent/CA2548173A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002548173A 2003-12-02 2004-12-01 Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof Abandoned CA2548173A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52608103P 2003-12-02 2003-12-02
US60/526,081 2003-12-02
PCT/IL2004/001098 WO2005054172A2 (en) 2003-12-02 2004-12-01 Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
CA2548173A1 true CA2548173A1 (en) 2005-06-16

Family

ID=34652413

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002548173A Abandoned CA2548173A1 (en) 2003-12-02 2004-12-01 Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof

Country Status (7)

Country Link
US (2) US7425651B2 (https=)
EP (1) EP1689696A2 (https=)
JP (1) JP2007514663A (https=)
CN (1) CN1902156A (https=)
AU (1) AU2004295206A1 (https=)
CA (1) CA2548173A1 (https=)
WO (1) WO2005054172A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005054172A2 (en) * 2003-12-02 2005-06-16 Ramot At Tel-Aviv University Ltd. Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof
CA2630666A1 (en) 2005-12-07 2007-06-14 Sepal Pharma Ltd. Jasmonate derivatives, pharmaceutical compositions and methods of use thereof
US20090291904A1 (en) * 2005-12-07 2009-11-26 Yoel Kashman Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US9284274B2 (en) 2005-12-07 2016-03-15 Ramot At Tel-Aviv University Ltd. Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
CA2657375A1 (en) * 2006-07-10 2008-01-17 Ramot At Tel-Aviv University Ltd. Combination methods of treating cancer
WO2008111088A2 (en) 2007-03-15 2008-09-18 Ramot At Tel-Aviv University Ltd. Jasmonate based assays for identifying compounds that selectively inhibit mitochondrial bound hexokinases
US9284252B2 (en) 2009-06-09 2016-03-15 Sepal Pharma Ltd. Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
CN103140223A (zh) * 2010-05-19 2013-06-05 布罗迪健康科学有限公司 茉莉酮酸酯用于治疗心力衰竭及相关心脏病症的用途
RU2623878C2 (ru) 2010-12-10 2017-06-29 Броади Хэлс Сайенсис, Эл Эл Си Применение жасмоната для лечения нарушения функции мочевого пузыря
WO2013040556A1 (en) 2011-09-16 2013-03-21 Nanocare Technologies, Inc. Compositions of jasmonate compounds and methods of use
CA2971870A1 (en) 2014-12-31 2016-07-07 Nanocare Technologies, Inc. Jasmonate derivatives and compositions thereof
WO2017168416A1 (en) 2016-03-28 2017-10-05 Vidac Pharma Ltd. Stable pharmaceutical compositions for topical administration and uses thereof
US11266639B2 (en) 2016-11-07 2022-03-08 Vidac Pharma Ltd. Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers
WO2018083704A1 (en) 2016-11-07 2018-05-11 Vidac Pharma Ltd. Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0441414A (ja) * 1990-06-04 1992-02-12 Fujisawa Pharmaceut Co Ltd 育毛料
US5118711A (en) * 1990-09-27 1992-06-02 International Flavors & Fragrances Inc. Ketone, ketoesters and alcohol in repelling insects; use of aliphatic ester in attracting insects and process and apparatus for determination of insect repellency and attractancy
US5436226A (en) * 1993-11-03 1995-07-25 The United States Of America, As Represented By The Secretary Of Agriculture Natural suppression of sprouting in stored potatoes using jasmonates
ES2176686T3 (es) * 1996-02-28 2002-12-01 Nippon Zeon Co Regulador del crecimiento para plantas de cultivo y procedimiento para la regulacion del crecimiento de plantas de cultivo.
JP3568325B2 (ja) 1996-07-12 2004-09-22 株式会社ノエビア 抗アンドロゲン剤及び養毛剤並びに毛髪用化粧料
US6469061B1 (en) * 2001-04-04 2002-10-22 Ramot University Authority For Applied Research And Industrial Development Limited Jasmonate pharmaceutical composition for treatment of cancer
WO2005054172A2 (en) * 2003-12-02 2005-06-16 Ramot At Tel-Aviv University Ltd. Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof

Also Published As

Publication number Publication date
WO2005054172A3 (en) 2005-07-07
EP1689696A2 (en) 2006-08-16
WO2005054172A2 (en) 2005-06-16
US20070142474A1 (en) 2007-06-21
AU2004295206A1 (en) 2005-06-16
CN1902156A (zh) 2007-01-24
US20080319066A1 (en) 2008-12-25
US7425651B2 (en) 2008-09-16
US7683211B2 (en) 2010-03-23
JP2007514663A (ja) 2007-06-07

Similar Documents

Publication Publication Date Title
US7683211B2 (en) Jasmonate derivative compounds pharmaceutical compounds and methods of use thereof
US20120289718A1 (en) Compounds useful in the synthesis of halichondrin b analogs
US20230278955A1 (en) Vitamin d3 derivatives and pharmaceutical use thereof
CN110914254A (zh) 唑类取代的吡啶化合物
ES2787700T3 (es) Compuestos de dihidropirimidina-2-ona y usos medicinales de los mismos
CA2632653C (en) Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof in the treatment of cancer
TWI899933B (zh) 經取代吲唑丙酸衍生化合物及其用途
EP2833877A1 (en) Novel targeting agents for diagnostic and therapeutic indications
WO2008067451A1 (en) Novel 3-benzylidine and 3-benzyl substituted chromanones
EP3475260A1 (en) Compounds for use as an anti-bacterial or anti-fungal agent and as a zinc sensor
JP2021512879A (ja) プロブコール誘導体及びその調製方法と使用
US20070004803A1 (en) Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase
US9284274B2 (en) Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
CA2677353A1 (en) Halogen substituted alkynes and their use in the treatment of cancer
Hentschel et al. Fluorescent analogs of the marine natural product psammaplin A: synthesis and biological activity
HK1096382A (en) Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof
KR101878621B1 (ko) 프로드러그
WO2014168139A1 (ja) ３，４，５－トリカフェオイルキナ酸の製造方法
US5741814A (en) Cyclooctadiene derivatives
JP2008201751A (ja) ＭＡＰＫＫ核外移行阻害物質ｐｅｕｍｕｓｏｌｉｄｅＡの類縁体とその利用
HK40026055A (en) Pyridine compound substituted with azole
JPH07258259A (ja) シクロオクタジエン誘導体
PL228430B1 (pl) 3’-Amino-4-etylochalkon i sposób otrzymywania 3’-amino- -4-etylochalkonu
PL228433B1 (pl) 3’-Amino-3-metoksy-4-benzyloksychalkon i sposób otrzymywania 3’-amino-3-metoksy-4-benzyloksychalkonu
PL217374B1 (pl) Chlorolakton 5-(1-chloroetylo)-4-(2,6,6-trimetylocykloheks-2-en-1-ylo)dihydrofuran-2(3H)-on i sposób otrzymywania 5-(1-chloroetylo)-4-(2,6,6-trimetylocykloheks-2-en-1-ylo)dihydrofuran-2(3H)-onu

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead